Glacial Pharmaceuticals Private Limited
About Glacial Pharmaceuticals Private Limited
Data last updated:
Glacial Pharmaceuticals Private Limited is a private limited company based in Thane, Maharashtra, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 27 June 2007 and has been in existence for over 19 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24232MH2007PTC172028. Its GSTIN is 10AADCG3925C1ZC (Bihar).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹10 Lakh. It is led by directors including Ashutosh Kumar and Bishwa Bhushan Bharti.
Its last annual general meeting (AGM) was held on 27 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Vighnesh Chs Shop No – 7 Plot No – 99 Sector – 4 Koparkhairane, Thane, Maharashtra, India – 400709.
As per the financials filed for FY 2025, the company reported a revenue of ₹1.83 Cr, a growth of 17% compared to the previous year. For the same year it recorded a net profit of ₹17.43 Lakh (net margin 9.5%) and EBITDA of ₹23.63 Lakh (EBITDA margin 12.9%). Revenue has grown at a compounded annual rate (CAGR) of 25% over three years and 10% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressVighnesh Chs Shop No – 7 Plot No – 99 Sector – 4 Koparkhairane, Thane, Maharashtra, India – 400709
- IndustryPharma, Pharmaceutical Retailers & Distributors
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Glacial Pharmaceuticals Private Limited
The main business activity of Glacial Pharmaceuticals is wholesale and retail trade; repair of motor vehicles and motorcycles. In detail, this covers wholesale trade, except of motor vehicles and motorcycles.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Wholesale and retail trade; repair of motor vehicles and motorcycles | 46 | Wholesale trade, except of motor vehicles and motorcycles | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Glacial Pharmaceuticals Private Limited FY 2025 filings available
Glacial Pharmaceuticals Private Limited reported revenue of ₹1.83 Cr (up 17% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Glacial Pharmaceuticals Private Limited
Revenue has grown at a compounded annual rate (CAGR) of 10% over five years, including 17% growth in the latest year. EBITDA rose 28% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Glacial Pharmaceuticals Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹23.63 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹17.43 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Glacial Pharmaceuticals Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 12.9% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 9.5% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Glacial Pharmaceuticals are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Glacial Pharmaceuticals Private Limited
Glacial Pharmaceuticals Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Alcea Biotech Private Limited | ₹1.85 Cr (FY 2025) | •••• | •••• | 18.0% | •••• | Delhi, India |
| Charak Medisales Private Limited | ₹1.85 Cr (FY 2022) | •••• | •••• | 24.0% | •••• | Indore, Madhya Pradesh, India |
| Goyal Ispaat Udhyog Private Limited | ₹1.85 Cr (FY 2025) | •••• | •••• | -4.0% | •••• | Delhi, India |
| Skyways Healthcare Private Limited | ₹1.84 Cr (FY 2025) | •••• | •••• | 20.0% | •••• | Shahabad, Haryana, India |
| Othantic Pharmaceuticals Private Limited | ₹1.84 Cr (FY 2025) | •••• | •••• | 0.0% | •••• | Indore, Madhya Pradesh, India |
| Glacial Pharmaceuticals Private Limited this company | ₹1.83 Cr (FY 2025) | •••• | •••• | 17.0% | •••• | Thane, Maharashtra, India |
| Genirex Healthcare Private Limited | ₹1.83 Cr (FY 2024) | •••• | •••• | -1.0% | •••• | Mumbai, Maharashtra, India |
| Avery Pharmaceuticals Private Limited | ₹1.83 Cr (FY 2025) | •••• | •••• | 42.0% | •••• | Mumbai, Maharashtra, India |
| Balasia Pharmaceuticals Private Limited | ₹1.83 Cr (FY 2025) | •••• | •••• | 12.0% | •••• | Kolkata, West Bengal, India |
| Palas Pharmaceuticals Private Limited | ₹1.83 Cr (FY 2024) | •••• | •••• | -15.0% | •••• | Lucknow, Uttar Pradesh, India |
| Soin Pharmaceuticals Private Limited | ₹1.83 Cr (FY 2025) | •••• | •••• | 12.0% | •••• | Thiruvananthapuram, Kerala, India |
Peers are the five companies nearest above and the five nearest below Glacial Pharmaceuticals by revenue in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Glacial Pharmaceuticals Private Limited
Glacial Pharmaceuticals Private Limited is audited by P A PARASHAR & ASSOCIATES for the financial year 2019.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| P A PARASHAR & ASSOCIATES | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Glacial Pharmaceuticals Private Limited
Glacial Pharmaceuticals has 4 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Ashutosh Kumar | Director | 27 Jun 2007 | 19 Years 3 Months | Current |
| Bishwa Bhushan Bharti Also directs: Pda Life Science Private Limited, Aparna Architect and Engicons Private Limited, Innerva Realtors Private Limited and 5 more | Director | 23 Jan 2009 | 17 Years 8 Months | Current |
| Santosh Kumar Also directs: Pda Life Science Private Limited, Aparna Architect and Engicons Private Limited, Innerva Realtors Private Limited and 5 more | Director | 23 Jan 2009 | 17 Years 8 Months | Current |
| Arun Kumar Also directs: Pda Life Science Private Limited, Aparna Architect and Engicons Private Limited, Innerva Realtors Private Limited and 5 more | Director | 23 Jan 2009 | 17 Years 8 Months | Current |
Ownership and Shareholding of Glacial Pharmaceuticals Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Glacial Pharmaceuticals Private Limited
Glacial Pharmaceuticals Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Glacial Pharmaceuticals Private Limited
Employment history and EPFO contributions of people linked to Glacial Pharmaceuticals.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Glacial Pharmaceuticals Private Limited
Glacial Pharmaceuticals Private Limited has 5 board changes on record since 2007: 4 appointments and 1 cessation. The latest: Arun Kumar was appointed as Director on 23 Jan 2009.
Credit Ratings, Litigation & Regulatory Alerts for Glacial Pharmaceuticals Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Glacial Pharmaceuticals Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Glacial Pharmaceuticals Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Glacial Pharmaceuticals Private Limited
Glacial Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 10AADCG3925C1ZC | Bihar | Active | 01 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Glacial Pharmaceuticals Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Glacial Pharmaceuticals Private Limited
Glacial Pharmaceuticals is an active private limited company based in Thane, Maharashtra, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 27 June 2007 (19+ years old) and is registered under CIN U24232MH2007PTC172028.
Glacial Pharmaceuticals reported revenue of ₹1.83 Cr for FY 2025 (up 17% YoY).
Glacial Pharmaceuticals has 4 current directors:
- Ashutosh Kumar - Director
- Bishwa Bhushan Bharti - Director
- Santosh Kumar - Director
- Arun Kumar - Director
Glacial Pharmaceuticals reported a net profit of ₹17.43 Lakh (net margin 9.5%) and EBITDA of ₹23.63 Lakh (EBITDA margin 12.9%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Glacial Pharmaceuticals is 25% over three years and 10% over five years. In the latest year (FY 2025) revenue rose 17%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Glacial Pharmaceuticals is 10AADCG3925C1ZC, registered in Bihar.
The CIN (Corporate Identification Number) of Glacial Pharmaceuticals is U24232MH2007PTC172028. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Glacial Pharmaceuticals was incorporated on 27 June 2007, making it 19+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Glacial Pharmaceuticals by revenue are Alcea Biotech Private Limited, Charak Medisales Private Limited, Goyal Ispaat Udhyog Private Limited, Skyways Healthcare Private Limited, Othantic Pharmaceuticals Private Limited and 5 more, all in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals).
Arun Kumar was appointed as Director on 23 Jan 2009. Bishwa Bhushan Bharti was appointed as Director on 23 Jan 2009. Ranavijay Singh ceased to be Director on 23 Jan 2009. Glacial Pharmaceuticals has 5 board changes on record in total.
The registered office of Glacial Pharmaceuticals is at Vighnesh Chs Shop No – 7 Plot No – 99 Sector – 4 Koparkhairane, Thane, Maharashtra, India – 400709.